Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation

Fingolimod (FTY720, Gilenya), a sphingosine-1-phosphate receptor (S1PR) modulator, is one of the first-line immunomodulatory therapies for treatment of relapsing-remitting multiple sclerosis (MS). Human S1PR1 variants have been reported to have functional heterogeneity in vitro, suggesting that S1PR...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:JCI Insight
Hoofdauteurs: Tsai, Hsing-Chuan, Huang, Yingxiang, Garris, Christopher S., Moreno, Monica A., Griffin, Christina W., Han, May H.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Clinical Investigation 2016
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5033897/
https://ncbi.nlm.nih.gov/pubmed/27699272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.86462
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items